These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3437066

  • 1. Long-term antihypertensive effects and safety of nitrendipine in patients with mild, moderate, and severe hypertension.
    Kann J.
    J Clin Pharmacol; 1987 Dec; 27(12):945-50. PubMed ID: 3437066
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of a new calcium antagonist in severe hypertension.
    Burris JF, Santangelo RP, Mroczek WJ.
    J Clin Pharmacol; 1986 Dec; 26(8):593-7. PubMed ID: 3793949
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987 Dec; 34 Suppl 3():139-48. PubMed ID: 2894973
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
    Jain AK, McMahon FG, Ryan JR, Maronde R, Vlachakis N, Mroczek W.
    J Cardiovasc Pharmacol; 1984 Dec; 6 Suppl 7():S1053-9. PubMed ID: 6085366
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive monotherapy with nitrendipine in general practice.
    Braun H, Weber F.
    J Cardiovasc Pharmacol; 1991 Dec; 18 Suppl 1():S59-62. PubMed ID: 1723458
    [Abstract] [Full Text] [Related]

  • 10. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA, Drayer JI.
    J Cardiovasc Pharmacol; 1984 Dec; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
    Fagan TC, Sternleib C, Vlachakis N, Deedwania PC, Mehta JL.
    J Cardiovasc Pharmacol; 1984 Dec; 6 Suppl 7():S1109-13. PubMed ID: 6085377
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension.
    Nechwatal W, Berger J, Blumrich W, Bouzo H, Brandl K, Braun S, Laukaitis A, Müller G, Ryba W, Schreiegg J.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1806-14. PubMed ID: 2904755
    [Abstract] [Full Text] [Related]

  • 15. Different concepts in first-line treatment of essential hypertension. Comparison of a low-dose reserpine-thiazide combination with nitrendipine monotherapy. German Reserpine in Hypertension Study Group.
    Krönig B, Pittrow DB, Kirch W, Welzel D, Weidinger G.
    Hypertension; 1997 Feb; 29(2):651-8. PubMed ID: 9040452
    [Abstract] [Full Text] [Related]

  • 16. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B, Morgan TO, Gibson J, Anderson A.
    Drugs; 1987 Feb; 34 Suppl 3():109-19. PubMed ID: 2894971
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.